Delivery Order SPE2DB24D6044-SPE2DB25FLJNV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,582.57 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on July 14, 2025, with completion expected by July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $27,548.20 for the supply of Trulicity 3 mg/0.5 ml pen injectors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and Department of Defense...
- The Defense Logistics Agency awarded a delivery order valued at $10,142.67 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on August 18, 2025, with completion expected by August 19, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication commonly used within the Defense Health...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,801.80 for Trulicity 1.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a $3,348.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pens with an ultimate completion date of September 8, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a widely-used injectable diabetes medication, reflecting the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.99 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on June 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by June 27, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,137.38 for Trulicity 1.5 mg/0.5 ml pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical products...
- The Defense Logistics Agency awarded a $4,544.83 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pen injectors on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal pharmaceutical procurement channels to support military and...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJNVDelivery Order
The Defense Logistics Agency awarded a $3,155.25 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors with a completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems, reflecting AmerisourceBergen's ongoing role as a critical pharmaceutical supplier for Department of Defense medical needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitively awarded pharmaceutical contracts demonstrates its established capability to fulfill federal medical supply requirements across diverse therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/26/25 |